Identification of a small molecule inhibitor of the aminoglycoside 6'-N-acetyltransferase type Ib [AAC(6')-Ib] using mixture-based combinatorial libraries. 2018

Tung Tran, and Kevin Chiem, and Saumya Jani, and Brock A Arivett, and David L Lin, and Rupali Lad, and Verónica Jimenez, and Mary B Farone, and Ginamarie Debevec, and Radleigh Santos, and Marc Giulianotti, and Clemencia Pinilla, and Marcelo E Tolmasky
Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA.

The aminoglycoside, 6'-N-acetyltransferase type Ib [AAC(6')-Ib] is the most widely distributed enzyme among AAC(6')-I-producing Gram-negative pathogens and confers resistance to clinically relevant aminoglycosides, including amikacin. This enzyme is therefore an ideal target for enzymatic inhibitors that could overcome resistance to aminoglycosides. The search for inhibitors was carried out using mixture-based combinatorial libraries, the scaffold ranking approach, and the positional scanning strategy. A library with high inhibitory activity had pyrrolidine pentamine scaffold and was selected for further analysis. This library contained 738,192 compounds with functionalities derived from 26 different amino acids (R1, R2 and R3) and 42 different carboxylic acids (R4) in four R-group functionalities. The most active compounds all contained S-phenyl (R1 and R3) and S-hydromethyl (R2) functionalities at three locations and differed at the R4 position. The compound containing 3-phenylbutyl at R4 (compound 206) was a robust enzymatic inhibitor in vitro, in combination with amikacin it potentiated the inhibition of growth of three resistant bacteria in culture, and it improved survival when used as treatment of Galleria mellonella infected with aac(6')-Ib-harboring Klebsiella pneumoniae and Acinetobacter baumannii strains.

UI MeSH Term Description Entries
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000123 Acetyltransferases Enzymes catalyzing the transfer of an acetyl group, usually from acetyl coenzyme A, to another compound. EC 2.3.1. Acetyltransferase
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Tung Tran, and Kevin Chiem, and Saumya Jani, and Brock A Arivett, and David L Lin, and Rupali Lad, and Verónica Jimenez, and Mary B Farone, and Ginamarie Debevec, and Radleigh Santos, and Marc Giulianotti, and Clemencia Pinilla, and Marcelo E Tolmasky
January 2016, MedChemComm,
Tung Tran, and Kevin Chiem, and Saumya Jani, and Brock A Arivett, and David L Lin, and Rupali Lad, and Verónica Jimenez, and Mary B Farone, and Ginamarie Debevec, and Radleigh Santos, and Marc Giulianotti, and Clemencia Pinilla, and Marcelo E Tolmasky
December 2020, Antibiotics (Basel, Switzerland),
Tung Tran, and Kevin Chiem, and Saumya Jani, and Brock A Arivett, and David L Lin, and Rupali Lad, and Verónica Jimenez, and Mary B Farone, and Ginamarie Debevec, and Radleigh Santos, and Marc Giulianotti, and Clemencia Pinilla, and Marcelo E Tolmasky
October 2013, Bioorganic & medicinal chemistry letters,
Tung Tran, and Kevin Chiem, and Saumya Jani, and Brock A Arivett, and David L Lin, and Rupali Lad, and Verónica Jimenez, and Mary B Farone, and Ginamarie Debevec, and Radleigh Santos, and Marc Giulianotti, and Clemencia Pinilla, and Marcelo E Tolmasky
December 2023, bioRxiv : the preprint server for biology,
Tung Tran, and Kevin Chiem, and Saumya Jani, and Brock A Arivett, and David L Lin, and Rupali Lad, and Verónica Jimenez, and Mary B Farone, and Ginamarie Debevec, and Radleigh Santos, and Marc Giulianotti, and Clemencia Pinilla, and Marcelo E Tolmasky
September 2008, Biochemistry,
Tung Tran, and Kevin Chiem, and Saumya Jani, and Brock A Arivett, and David L Lin, and Rupali Lad, and Verónica Jimenez, and Mary B Farone, and Ginamarie Debevec, and Radleigh Santos, and Marc Giulianotti, and Clemencia Pinilla, and Marcelo E Tolmasky
September 2021, Biomedicines,
Tung Tran, and Kevin Chiem, and Saumya Jani, and Brock A Arivett, and David L Lin, and Rupali Lad, and Verónica Jimenez, and Mary B Farone, and Ginamarie Debevec, and Radleigh Santos, and Marc Giulianotti, and Clemencia Pinilla, and Marcelo E Tolmasky
July 1993, Antimicrobial agents and chemotherapy,
Tung Tran, and Kevin Chiem, and Saumya Jani, and Brock A Arivett, and David L Lin, and Rupali Lad, and Verónica Jimenez, and Mary B Farone, and Ginamarie Debevec, and Radleigh Santos, and Marc Giulianotti, and Clemencia Pinilla, and Marcelo E Tolmasky
December 2001, Antimicrobial agents and chemotherapy,
Tung Tran, and Kevin Chiem, and Saumya Jani, and Brock A Arivett, and David L Lin, and Rupali Lad, and Verónica Jimenez, and Mary B Farone, and Ginamarie Debevec, and Radleigh Santos, and Marc Giulianotti, and Clemencia Pinilla, and Marcelo E Tolmasky
November 1999, Antimicrobial agents and chemotherapy,
Tung Tran, and Kevin Chiem, and Saumya Jani, and Brock A Arivett, and David L Lin, and Rupali Lad, and Verónica Jimenez, and Mary B Farone, and Ginamarie Debevec, and Radleigh Santos, and Marc Giulianotti, and Clemencia Pinilla, and Marcelo E Tolmasky
January 2018, Frontiers in microbiology,
Copied contents to your clipboard!